Germline pathogenic and likely pathogenic variants in the BRCA1 and BRCA2 genes (BRCApv) account for 3–5% of breast cancer (BC) incidence and are linked to hereditary breast and ovarian cancer syndrome [1]. This evidence concerns the gene BRCA2 and breast cancer.